Global Small Cell Lung Cancer Therapeutics Market Size, Share, Growth, Demand, Forecast 2015-2019 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Small Cell Lung Cancer Therapeutics Market Size, Share, Growth, Demand, Forecast 2015-2019

Description:

Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. Get full report & TOC @: – PowerPoint PPT presentation

Number of Views:29

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Small Cell Lung Cancer Therapeutics Market Size, Share, Growth, Demand, Forecast 2015-2019


1
IT Services Market in Latin America
2015-2019Global Small Cell Lung Cancer
Therapeutics Market 2015-2019Global Small
Cell Lung Cancer Therapeutics Market
2015-2019Global Small Cell Lung Cancer
Therapeutics Market 2015-2019
Industry Size, Share, Global Trends, Demand,
Insights, Analysis, Research, Report, and
Forecast 2015- 2019
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
2
Report overview
Research Beam adds a report titled Global Small
Cell Lung Cancer Therapeutics Market 2015-2019
that provides latest market trends and
opportunities. The report offers detailed
analysis of the Small Cell Lung Cancer
Therapeutics Industry. Cancer occurs when, after
cell transformation, normal cells grow and
multiply without control. Lung cancer is a common
cause of mortality and morbidity in developed and
developing countries. Smoking is considered to be
the major cause of small cell lung cancer, though
it also occurs in non-smokers. Lung cancer can be
categorized into two types non-small cell lung
cancer and small cell lung cancer. Small cell
lung cancer constitutes roughly 10-15 percent of
all diagnosed cases of lung cancer. Small cell
lung cancer is categorized into two types small
cell carcinoma and combined small cell carcinoma.
It can be further classified into two stages
limited-stage small cell lung cancer and
extensive-stage small cell lung cancer. Small
cell lung cancer is caused by smoking tobacco, or
second hand smoking, or on exposure to asbestos,
chromium, arsenic, nickel, soot, or radon. The
common symptoms associated with lung cancer are
chest pain, incurable cough, blood in sputum,
fatigue, loss of appetite, unintentional weight
loss, shortness of breath, and wheezing. Small
cell lung cancer has a poor prognosis and gets
diagnosed only at the late stage of disease
progression, and hence, has a high mortality
rate. There are no therapies available to cure
small cell lung cancer in the market. As per
the Report, The Global Small Cell Lung Cancer
Therapeutics market to grow at a CAGR of 3.60
percent over the period 2014-2019.

3
Report overview
Covered in this Report Global Small Cell Lung
Cancer Therapeutics Market 2015-2019, has been
prepared based on an in-depth market analysis
with inputs from industry experts. The report
covers the Americas, and the APAC and EMEA
regions it also covers the Global Small Cell
Lung Cancer Therapeutics market landscape and its
growth prospects in the coming years. The report
also includes a discussion of the key vendors
operating in this market. Key Regions Americas
APAC EMEA Key Vendors
Bristol-Myers Squibb GlaxoSmithKline
Menarini Sanofi ZIOPHARM Oncology Other
Prominent Vendors Alchemia BioMarin
Pharmaceutical CellAct Pharma Cipla

4
Report overview
Market Driver High Unmet Need For a full,
detailed list, view our report Market
Challenge High Cost of Treatment Market
Trend Strategic Alliances Key Questions
Answered in this Report What will the market
size be in 2019 and what will the growth rate
be? What are the key market trends? What is
driving this market? What are the challenges to
market growth? Who are the key vendors in this
market space? What are the market opportunities
and threats faced by the key vendors? What are
the strengths and weaknesses of the key
vendors? Enquire about report _at_
http//www.researchbeam.com/global-small-cell-lung
-cancer-therapeutics-2015-2019-market/enquire-abou
t-report

5
Table of Contents
01. Executive Summary 02. List of
Abbreviations 03. Scope of the Report 04. Market
Research Methodology 05. Disease Overview 06.
Introduction 07. Market Landscape 08 Pipeline
Analysis 09. Market Segmentation by Therapeutic
Class of Drugs 10 Market Segmentation by Route of
Administration 11 Market Segmentation by Dosage
Form 12 Geographical Segmentation 13 Buying
Criteria 14 Market Growth Drivers 15 Drivers and
their Impact

6
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/global-small-cell-lung
-cancer-therapeutics-2015-2019-market
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_researchbeam.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
Stay With Us
About PowerShow.com